Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular disulfide-containing proteins on epithelial and mucosal surfaces represent a functional class of proteins, primarily mucins and viral attachment receptors, characterized by the presence of cysteine-mediated disulfide bridges (Thornton et al., 2008). These disulfide bonds are essential for the structural integrity and polymerization of mucins, which determine the viscoelastic properties of the protective mucus layer in the respiratory and gastrointestinal tracts. In pathological conditions such as cystic fibrosis and chronic obstructive pulmonary disease (COPD), oxidative stress leads to excessive disulfide cross-linking, resulting in hyperviscous mucus that is difficult to clear (Sadowska et al., 2006). Furthermore, many respiratory viruses, including SARS-CoV-2 and influenza, utilize disulfide-rich surface proteins to facilitate binding and entry into host cells (Hati & Bhattacharyya, 2020). Therapeutic intervention typically involves the use of thiol-based reducing agents, such as N-acetylcysteine, which cleave these disulfide bonds to reduce mucus viscosity and potentially disrupt viral infectivity (Aldini et al., 2018).
Reduction of extracellular disulfide bonds (S-S) to sulfhydryl groups (S-H), resulting in the cleavage of protein cross-links and reduction of macromolecular viscosity (Aldini et al., 2018).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular disulfide-containing proteins on epithelial and mucosal surfaces.